Our Pipeline

Anti-CD20 monoclonal antibody

Reference product primary conditions:

  • Non‑Hodgkin’s lymphoma
  • Chronic lymphocytic leukemia
  • Rheumatoid arthritis
  • Granulomatosis with polyangiitis
  • Microscopic polyangiitis

Anti-tumor necrosis factor‑alpha (anti‑TNF) monoclonal antibody

Reference product primary conditions:

  • Rheumatoid arthritis
  • Plaque psoriasis
  • Crohn’s disease
  • Ulcerative colitis
  • Psoriatic arthritis
  • Ankylosing spondylitis

Anti-epidermal growth factor receptor (anti‑EGFR) monoclonal antibody

Reference product primary conditions:

  • Colorectal cancer
  • Head and neck cancer

Monoclonal antibody that specifically binds to the complement protein C5

Reference product primary conditions:

  • Paroxysmal nocturnal hemoglobinuria
  • Atypical hemolytic uremic syndrome
  • Generalized myasthenia gravis

Previous: Approved Products

Next: clinical trials